Chirfi Guindo - Aug 5, 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Chief Marketing Officer
Signature
/s/ Kelly Grez, as attorney-in-fact for Mr. Chirfi Guindo
Stock symbol
MRK
Transactions as of
Aug 5, 2024
Transactions value $
$2,245,133
Form type
4
Date filed
8/6/2024, 12:20 PM
Previous filing
May 2, 2024
Next filing
Dec 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $4.25M +36.9K +176.72% $115.20 57.8K Aug 5, 2024 Direct F1
transaction MRK Common Stock Tax liability -$2.01M -17.4K -30.13% $115.20 40.4K Aug 5, 2024 Direct
holding MRK Common Stock-401(k) Plan 53.8 Aug 5, 2024 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -36.9K -50% $0.00 36.9K Aug 5, 2024 Common Stock 36.9K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through July 8, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025 or, if such date is not a business day, the business day immediately thereafter.